EquiTech Corporation
TSX VENTURE : EQT

EquiTech Corporation

April 03, 2006 17:46 ET

EquiTech Announces Change in Management

EDMONTON, ALBERTA--(CCNMatthews - April 3, 2006) - EquiTech Corporation (TSX VENTURE:EQT) ("EquiTech") is pleased to announce that Dr. Fakhreddin Jamali has accepted the position of Chief Executive Officer. Dr. Jamali is currently the Chief Scientific Officer of EquiTech and is one of the founders of the company.

James Chivers-Wilson, President and CEO of EquiTech has resigned effective March 31, 2006. EquiTech would like to thank Mr. Chivers-Wilson for all of his efforts over the past years and wish him the best in his future endeavours.

About EquiTech Corporation

EquiTech Corporation is a junior specialty pharmaceutical company focused on the area of pharmaceutical reformulations and bio-absorption. The Company trades on the TSX Venture Exchange under the symbol EQT. For further information, visit www.equitechcorporation.com.


The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • EquiTech Corporation
    Kerry Brown
    Chairman of the Board
    (780) 460-1242